Technology
Health
Biotechnology

Cytokinetics

3,198

$20.71
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.05%) Today
$0.00 (0.00%) As of 6:03 PM EDT after-hours

Why Robinhood?

You can buy or sell Cytokinetics and other stocks, options, ETFs, and crypto commission-free!

About CYTK

Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical trial in patients with ALS, known as BENEFIT-ALS (Blinded Evaluation of Neuromuscular Effects and Functional Improvement with Tirasemtiv in ALS). Read More The company was founded on August 5, 1997 and is headquartered in South San Francisco, CA.

CEO
Robert I. Blum
Employees
156
Headquarters
South San Francisco, California
Founded
1997
Market Cap
1.23B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
713.80K
High Today
$20.81
Low Today
$19.69
Open Price
$20.81
Volume
1.26M
52 Week High
$23.04
52 Week Low
$7.73

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
US
North America

CYTK News

ReutersMay 25

Edited Transcript of CYTK earnings conference call or presentation 6-May-20 8:30pm GMT

Q1 2020 Cytokinetics Inc Earnings Call South San Francisco May 26, 2020 (Thomson StreetEvents) -- Edited Transcript of Cytokinetics Inc earnings conference cal
7

CYTK Earnings

-$0.66
-$0.44
-$0.22
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 6, After Hours

You May Also Like

VCYT
APYX
OLN
SMED
JHAA
TTEK
NUVA
MTSL
IFJPY
IQM
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy CYTK

Market Price$20.71
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Cytokinetics stock and options commission-free.
LearnBlogCareersHelpLog InSign Up